Thomas E. Freese, Ph.D., Co-Director, UCLA Integrated Substance Abuse Programs, Co-Director, Pacific Southwest Addiction Technology Transfer Center (HHS Region 9)
Randolph Holmes, M.D., Medical Director, PIH Health and Los Angeles Centers for Alcohol and Drug Abuse
Alexander Kuo, M.D., FAASLD, Medical Director, Liver Transplantation, Cedars-Sinai Medical Center Stephen Pandol, M.D., Director, Basic and Translational Pancreas Research and Leader of Translational Oncology and Professor of Medicine, Cedars Sinai-Medical Center and David Geffen School of Medicine at UCLA
This Lecture Series presentation will provide current information on alcohol use disorder trends and provide strategies for clinicians to assess and treat alcohol use disorder. A detailed review of the negative health impacts of alcohol consumption, especially as it relates to liver and pancreatic diseases, will be discussed. Participants will be able to address the synergistic effect of alcohol and secondary risk factors such as diet, viral hepatitis, and gender on the development and progression of alcoholic liver and pancreatic diseases. Understanding the relationship between the diseases and risk factors allows for the development of more effective prevention, assessment, and treatment measures to be utilized by healthcare professionals. Participants will gain a deeper understanding of alcohol use disorders in the community, and identify current assessment and treatment options for alcoholism and alcoholic liver and pancreatic diseases. Strategies in managing the rise of alcohol consumption due to the COVID-19 pandemic will also be discussed. A panel discussion with the presenters will follow the lecture. This portion of the presentation is intended to assist SUD providers in translating the information provided by the presenters into meaningful encounters with patients.